This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Davies, M. G. Articles by Hagen, P.-O. Search for Related Content PubMed PubMed Citation Articles by Davies, M. G. Articles by Hagen, P.-O. Social Bookmarking                         What's this?

Ramipril and Experimental Vein Graft Intimal Hyperplasia

Vascular Biology and Atherosclerosis Research Laboratory, Department of Surgery, Duke University Medical Center

Michael L. Klyachkin

Vascular Biology and Atherosclerosis Research Laboratory, Department of Surgery, Duke University Medical Center

Lizzie Barber

Vascular Biology and Atherosclerosis Research Laboratory, Department of Surgery, Duke University Medical Center

Einar Svendsen

Vascular Biology and Atherosclerosis Research Laboratory, Department of Surgery, Duke University Medical Center

Per-Otto Hagen

Department of Biochemistry, Duke University Medical Center, Durham, North Carolina

Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce the intimal proliferation in animal models of arterial angioplasty and vein bypass grafting. This study examines the effect of high-dose ramipril, an ACE inhibitor that does not contain a sulfhydryl group, on the development of intimal hyperplasia in experimental vein bypass grafts. Twenty New Zealand White rabbits underwent common carotid interposition bypass grafting. Twelve were treated with ramipril (2mg/kg/day; po) five days prior to surgery and thereafter until harvest. The remaining 8 animals were used as controls. Vein grafts were harvested at twenty-eight days by pressure fixation (80 mmHg). The grafts were sectioned into proximal, middle, and distal thirds, and the thickness of the intima and the media and the area of the lumen from each segment were determined by videomorphometry. The effect of ramipril on the [H³]thymidine incorporation into DNA of serum-stimulated smooth muscle cells (culture passage 6 to 12) was also assessed. There was a 50% mortality rate in the rabbits that received ramipril, and this was assumed to be related to the high dose of the drug. Ramipril treatment reduced mean vein graft intimal area by 34% (P > 0.05), but this was accompanied by an increase of 73% in the mean medial area of the vein grafts as compared with controls. These changes resulted in a decrease in the mean intimal ratio (intima/[intima + media]) by 39% in the ramipril group as compared with controls. Ramipril did not inhibit [H3]thymidine incor poration into DNA of serum-stimulated smooth muscle cells. This study shows that treatment with the nonsulfhydryl ACE inhibitor ramipril, even at a high dose, produces only a marginal reduction in the formation of intimal hyperplasia in experimental vein grafts.

Angiology, Vol. 46, No. 2, 91-97 (1995)
DOI: 10.1177/000331979504600201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?